Expression of the type III TGF-β receptor is negatively regulated by TGF-β
Open Access
- 24 February 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 29 (5), 905-912
- https://doi.org/10.1093/carcin/bgn049
Abstract
The type III transforming growth factor-beta receptor (TβRIII or betaglycan) is a ubiquitously expressed transforming growth factor-beta (TGF-β) superfamily coreceptor with essential roles in embryonic development. Recent studies have defined a role for TβRIII in the pathogenesis of human cancers, with frequent loss of TβRIII expression at the message and protein level. Mechanisms for the loss of TβRIII expression remain to be fully defined. Advanced human cancers often have elevated circulating levels of TGF-β1. Here, we define a specific role for TGF-β1 in negatively regulating TβRIII at the message level in breast and ovarian cancer models. TGF-β1 decreased TβRIII message and protein levels in ovarian (Ovca420) and breast cancer (MDA-MB-231) cell lines in both a dose- and time-dependent manner. TGF-β1-mediated TβRIII repression is mediated by the type I TGF-β receptor/Smad2/3 pathway as the activin receptor-like kinase 5 (ALK5) inhibitor, SB431542, abrogated this effect, while the expression of constitutively active ALK5 was sufficient to repress TβRIII expression. Mechanistically, TGF-β1 does not affect TβRIII messenger RNA (mRNA) stability, but instead directly regulates the TβRIII promoter. We define alternative promoters for the TGFBR3 gene, a distal and proximal promoter. Although both promoters are active, only the proximal promoter was responsive and negatively regulated by TGF-β1 and constitutively active ALK5. Taken together, these studies define TGF-β1-mediated downregulation of TβRIII mRNA expression through effects on the ALK5/Smad2/3 pathway on the TGFBR3 gene proximal promoter as a potential mechanism for decreased TβRIII expression in human cancers.Keywords
This publication has 29 references indexed in Scilit:
- Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and InvasionCancer Research, 2007
- The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate CancerCancer Research, 2007
- The type III TGF-β receptor suppresses breast cancer progressionJCI Insight, 2007
- Betaglycan induces TGF-β signaling in a ligand-independent manner, through activation of the p38 pathwayCellular Signalling, 2006
- X chromosomal abnormalities in basal-like human breast cancerCancer Cell, 2006
- Fibroblast Growth Factor 9 Has Oncogenic Activity and Is a Downstream Target of Wnt Signaling in Ovarian Endometrioid AdenocarcinomasCancer Research, 2006
- Role of Transforming Growth Factor Beta in Human CancerJournal of Clinical Oncology, 2005
- Cloning the Promoter for Transforming Growth Factor-β Type III ReceptorPublished by Elsevier BV ,1999
- Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the HeartScience, 1999
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997